December 10, 2025 - 02:27

MONTPELLIER, France, December 09, 2025—In a recent announcement, Medincell's CEO, Christophe Douat, expressed optimism regarding the company’s financial performance and strategic direction. The firm has demonstrated considerable growth momentum, entering what Douat describes as "the most transformative years in Medincell’s history."
The company's flagship product, UZEDY, has shown strong market performance, contributing positively to the overall financial results. Looking ahead, the anticipated launch of olanzapine LAI in the coming year is expected to serve as a significant growth catalyst for Medincell. This launch aligns with the company’s Shift to Growth strategy, which aims to diversify its product offerings and enhance market presence.
Furthermore, Medincell is advancing its collaboration with AbbVie, marking the initiation of their first joint program. This partnership is expected to bolster Medincell’s innovation pipeline and reinforce its commitment to delivering cutting-edge solutions in the healthcare sector. Overall, the company remains focused on leveraging its current successes to drive future growth.
September 12, 2026 - 17:41
Should Income Investors Worry About Pfizer's Dividend?Pfizer has become a popular topic among income focused investors, largely because its dividend yield sits near 6 percent. That is far above the average yield found in the broader market, and for...
September 12, 2026 - 01:01
Social Security COLA is likely to increase next year. So could the pressure to change it.The annual cost-of-living adjustment for Social Security recipients is projected to increase next year, offering modest relief to millions of retirees and disabled workers. According to estimates...
September 11, 2026 - 05:04
Constellation Brands to Report Second Quarter Fiscal 2027 Financial Results on October 6, 2026, After Market Close and Host Conference Call on October 7, 2026, at 8:00 AM ETConstellation Brands has scheduled the release of its second quarter fiscal 2027 financial results for Tuesday, October 6, 2026. The company will publish the earnings report after U.S. markets...
September 10, 2026 - 00:44
Gloo Holdings, Inc. Reports Second Quarter 2026 Financial ResultsBOULDER, Colo., September 09, 2026 - Gloo Holdings, Inc. (Nasdaq: GLOO), a technology platform built for the faith and flourishing community, reported financial results for its second quarter of...